Psyence Biomedical (PBM) Other Non-Current Assets (2023 - 2026)
Psyence Biomedical (PBM) posted Other Non-Current Assets of $47191.0 for Q1 2026, little changed on a QoQ basis from $47191.0 in Q3 2025, and up 31.22% year-over-year from $35964.0 in Q1 2025.
Analysis
Psyence Biomedical (PBM) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Psyence Biomedical has reported Other Non-Current Assets for 4 years, with the latest figure at $47191.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 31.22% year-over-year to $47191.0 in Q1 2026; TTM through Mar 2026 was $47191.0, a 31.22% increase from a year earlier, with the FY2026 full-year figure at $47191.0, up 31.22% from the prior year.
- Other Non-Current Assets was $47191.0 for Q1 2026 at Psyence Biomedical, roughly flat from $47191.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $47191.0 in Q3 2025, with the low at -$595172.0 in Q3 2023.
- Average Other Non-Current Assets over 4 years is -$53706.1, with a median of $29684.5 recorded in 2024.
- The largest YoY upside for Other Non-Current Assets was 104.98% in 2024 against a maximum downside of 0.33% in 2024.
- Over 4 years, Other Non-Current Assets stood at -$595172.0 in 2023, then surged by 104.98% to $29611.0 in 2024, then soared by 59.37% to $47191.0 in 2025, then changed by 0.0% to $47191.0 in 2026.
- The last three Other Non-Current Assets figures came in at $47191.0 (Q1 2026), $47191.0 (Q3 2025), and $35964.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.54 Bn | 192.56 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 131.10 Bn | 123.25 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 60.69 Bn | 55.51 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 53.54 Bn | 48.40 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | 29.59 Mn |
| 10 | Psyence Biomedical | 2.64 Mn | 2.64 Mn | - | 47,191.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 47,191.00 |
| Sep 30, 2025 | 47,191.00 |
| Mar 31, 2025 | 35,964.00 |
| Sep 30, 2024 | 29,611.00 |
| Mar 31, 2024 | 29,684.53 |
| Sep 30, 2023 | -595,172.00 |
| Mar 31, 2023 | 29,587.85 |